The global nephrology community recognises the need for a cohesive plan to address the
problem of chronic kidney disease (CKD). In July, 2016, the International Society of …

Background. The study aimed at studying efficacy and adverse effects of pulse
cyclophosphamide (pCyc) treatment and to compare it to continuous cyclophosphamide …

The pathology of vasculitis involves inflammation and necrosis of blood-vessel walls. The
clinical expression depends on the site, type, and size of involved vessels, and the severity …

The continuing morbidity of patients with vasculitis despite the improved prognosis with
aggressive therapy, underlines the need for accurate disease assessment We have devised …

Objective. To develop and validate the Vasculitis Damage Index (VDI) for the standardized
clinical assessment of damage in the systemic vasculitides. Methods. Using a nominal group …

Intravenous immunoglobulin (IVIg) is a potential alternative treatment for anti‐neutrophil
cytoplasm antibody (ANCA)‐associated systemic vasculitis (AASV) with less toxicity than …

Background and objectives: Extended hemodialysis using a high cut-off dialyzer (HCO-HD)
removes large quantities of free light chains in patients with multiple myeloma. However, the …

Although cyclophosphamide and prednisolone are effective in treating systemic vasculitis,
the optimum treatment regimes and duration of treatment are unknown. We randomized 54 …

Glomerular-derived proteins may activate tubular cells to express the macrophage-directed
chemokine monocyte chemoattractant protein-1 (MCP-1/CCL2). Macrophages at interstitial …

HIV-positive individuals are at increased risk for kidney disease, including HIV-associated
nephropathy, noncollapsing focal segmental glomerulosclerosis, immune-complex kidney …